Soluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy
Abstract Vascular mechanisms of Alzheimer’s disease (AD) may constitute a therapeutically addressable biological pathway underlying dementia. We previously demonstrated that soluble pathogenic forms of tau (tau oligomers) accumulate in brain microvasculature of AD and other tauopathies, including pr...
Main Authors: | Stacy A. Hussong, Andy Q. Banh, Candice E. Van Skike, Angela O. Dorigatti, Stephen F. Hernandez, Matthew J. Hart, Beatriz Ferran, Haneen Makhlouf, Maria Gaczynska, Pawel A. Osmulski, Salome A. McAllen, Kelly T. Dineley, Zoltan Ungvari, Viviana I. Perez, Rakez Kayed, Veronica Galvan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-04-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-37840-y |
Similar Items
-
Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
by: Priyanka Rawat, et al.
Published: (2022-10-01) -
Targeting tauopathy with engineered tau-degrading intrabodies
by: Gilbert Gallardo, et al.
Published: (2019-10-01) -
Nasal Rifampicin Halts the Progression of Tauopathy by Inhibiting Tau Oligomer Propagation in Alzheimer Brain Extract-Injected Mice
by: Tomohiro Umeda, et al.
Published: (2022-01-01) -
TauLUM, an in vivo Drosophila sensor of tau multimerization, identifies neuroprotective interventions in tauopathy
by: Simon A. Levy, et al.
Published: (2022-09-01) -
Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
by: Cyril Laurent, et al.
Published: (2018-02-01)